Kymera Therapeutics (KYMR) Retained Earnings (2019 - 2025)
Historic Retained Earnings for Kymera Therapeutics (KYMR) over the last 7 years, with Q3 2025 value amounting to -$979.0 million.
- Kymera Therapeutics' Retained Earnings fell 4314.96% to -$979.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$979.0 million, marking a year-over-year decrease of 4314.96%. This contributed to the annual value of -$754.6 million for FY2024, which is 4217.75% down from last year.
- As of Q3 2025, Kymera Therapeutics' Retained Earnings stood at -$979.0 million, which was down 4314.96% from -$896.8 million recorded in Q2 2025.
- Kymera Therapeutics' 5-year Retained Earnings high stood at -$141.8 million for Q1 2021, and its period low was -$979.0 million during Q3 2025.
- Its 5-year average for Retained Earnings is -$489.9 million, with a median of -$463.5 million in 2023.
- In the last 5 years, Kymera Therapeutics' Retained Earnings tumbled by 8732.37% in 2022 and then crashed by 3243.61% in 2024.
- Quarter analysis of 5 years shows Kymera Therapeutics' Retained Earnings stood at -$229.0 million in 2021, then crashed by 67.61% to -$383.8 million in 2022, then tumbled by 38.29% to -$530.8 million in 2023, then crashed by 42.18% to -$754.6 million in 2024, then fell by 29.74% to -$979.0 million in 2025.
- Its last three reported values are -$979.0 million in Q3 2025, -$896.8 million for Q2 2025, and -$820.2 million during Q1 2025.